Raj Nigam
Overview
Explore the profile of Raj Nigam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pang K, Yunis M, Haider A, Freeman A, Hadway P, Nigam R, et al.
Clin Genitourin Cancer
. 2024 Sep;
22(5):102189.
PMID: 39232874
Introduction: Frozen section examination (FSE) of the tumor resection margins is important during penile-preserving surgery (PPS) in penile cancer. The margin status will impact on how much penile or urethral...
2.
Tang S, Akers C, Alnajjar H, Ayres B, Baldini C, Embleton-Thirsk A, et al.
Pilot Feasibility Stud
. 2024 Apr;
10(1):61.
PMID: 38600541
Background: Penile cancer is a rare male genital malignancy. Surgical excision of the primary tumour is followed by radical inguinal lymphadenectomy if there is metastatic disease detected by biopsy, fine...
3.
Pang K, Fallara G, Hemat M, Ghosh A, Haider A, Freeman A, et al.
Int J Impot Res
. 2024 Feb;
PMID: 38424353
Penile cancer (PeCa) is rare, and the oncological outcomes in younger men are unclear. We aimed to analyse and compare oncological outcomes of men age ≤50 years (y) and >50...
4.
Pang K, Fallara G, Tang S, Haider A, Freeman A, Hadway P, et al.
Urol Oncol
. 2023 Oct;
41(12):488.e11-488.e18.
PMID: 37903660
Background: Squamous cell carcinoma (SCC) of the scrotum is a rare and aggressive cancer. There are no established guidelines on the management of scrotal SCC. Objective: To analyze the clinical...
5.
Reddy D, van Son M, Peters M, Bertoncelli Tanaka M, Dudderidge T, Cullen E, et al.
J Med Econ
. 2023 Sep;
26(1):1099-1107.
PMID: 37656223
Aims: Focal therapy treats individual areas of tumour in non-metastatic prostate cancer in patients unsuitable for active surveillance. The aim of this work was to evaluate the cost-effectiveness of focal...
6.
Pang K, Girling B, Osinibi E, Sawhney P, Haider A, Freeman A, et al.
BJU Int
. 2023 May;
132(3):337-342.
PMID: 37169730
Objective: To report the oncological survival outcomes of men with penile sarcomatoid squamous cell carcinoma (sSCC). Patients And Methods: A retrospective analysis of men with penile sSCC diagnosed between January...
7.
Schifano N, Fallara G, Rezvani S, Pozzi E, Churchill J, Castiglione F, et al.
World J Urol
. 2023 Apr;
41(6):1581-1588.
PMID: 37019998
Purpose: To describe our surgical technique and report the oncological outcomes and complication rates using a fascial-sparing radical inguinal lymphadenectomy (RILND) technique for penile cancer patients with cN+ disease in...
8.
Habashy D, Reddy D, Peters M, Shah T, van Son M, van Rossum P, et al.
J Urol
. 2023 Apr;
210(1):108-116.
PMID: 37014172
Purpose: In older patients who do not wish to undergo watchful waiting, focal therapy could be an alternative to the more morbid radical treatment. We evaluated the role of focal...
9.
Wardak S, Pang K, Castiglione F, Lindsay J, Walkden M, Heffernan Ho D, et al.
BJU Int
. 2022 Aug;
131(1):73-81.
PMID: 35986901
Objectives: To report the management outcomes of men with ≤20-mm small testicular masses (STMs) and to identify clinical and histopathological factors associated with malignancy. Patients And Methods: A retrospective analysis...
10.
Reddy D, Peters M, Shah T, van Son M, Bertoncelli Tanaka M, Huber P, et al.
Eur Urol
. 2022 Feb;
81(4):407-413.
PMID: 35123819
Background: Focal therapy aims to treat areas of cancer to confer oncological control whilst reducing treatment-related functional detriment. Objective: To report oncological outcomes and adverse events following focal high-intensity focused...